Brind.
  1. Azenta provides biological sample management and genomic services.

Lawrence Lin was named CFO of Azenta, while Marotta was appointed CEO, and Stephens Inc. became an analyst.

3 reports, 3 independent Updated Aug 11
Gone quiet Reached 2 outlets in its first 24 hours
Reports
3
Developments
2
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Lawrence Lin was named CFO of Azenta, while Marotta was appointed CEO, and Stephens Inc. became an analyst.

Who's involved

What this event is mainly about
Lawrence LinMarotta

How it developed

Newest first. Tap a step to see who reported it.
  1. Lawrence Lin assumes the role of CFO at Marotta.1 source
  2. Azenta appointed Marotta as CEO and Lawrence Lin as CFO.1 source

Keep exploring

Part of

Azenta provides biological sample management and genomic services.

Also in this story

All 4 developments

The entities involved

  • Lawrence Lin

    researcher ORCID 0000-0003-4248-9740

    Nothing else this week.

  • Marotta

    company in Morristown, United States

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • fool.com
  • StockStoryThe Top 5 Analyst Questions From Azenta’s Q2 Earnings Call Azenta’s Q2 results were met with a significant negative market reaction following a flat sales performance that missed Wall Street’s revenu
  • PR NewswireAzenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance BURLINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today